Seer, Inc. (SEER) NASDAQ

2.21

+0.015(+0.68%)

Updated at July 02 01:59PM

Currency In USD

Seer, Inc.

Address

3800 Bridge Parkway

Redwood City, CA 94065

United States of America

Phone

650 453 0000

Sector

Healthcare

Industry

Biotechnology

Employees

134

First IPO Date

December 04, 2020

Key Executives

NameTitlePayYear Born
Dr. Omid C. Farokhzad M.D., Ph.D.Founder, Chief Executive Officer, & Chair of the Board of Directors1.19M1969
Mr. David R. HornPresident,Treasurer & Chief Financial Officer746,6521968
Kenny RossChief Operations & Product Officer0N/A
Dr. Serafim Batzoglou Ph.D.Chief Data Officer0N/A
Mr. Martin Goldberg Ph.D.Senior Vice President of Product Development0N/A
Dr. Asim Siddiqui Ph.D.Senior Vice President of Research & Tech Development0N/A
Ms. Marissa DixonChief People Officer0N/A

Description

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.